A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis
Status:
Not yet recruiting
Trial end date:
2023-03-14
Target enrollment:
Participant gender:
Summary
This study is a proof-of-concept study to demonstrate if a daily dose of a 2-days
pre-treatment of Fexofenadine 180mg is effective in alleviating the AR symptoms and to assess
the additional benefit to the patient in terms of preventing Allergic Rhinitis (AR) symptoms.
The total study duration per participant is expected at least 4 months, depending on the
timing of the screening visit. 5 visits are planned, screening, confirmation inclusion
challenge, randomization visit, challenge and end of study visit.